Martin Shkreli livestreamed himself violating lifetime pharma ban, FTC says
The FTC and seven state attorneys general allege Martin Shkreli violated his lifetime ban from the pharmaceutical industry. He livestreamed himself discussing industry matters, including biotech stocks. The ban was imposed after a trial found him guilty of organizing an illegal scheme to monopolize the drug Daraprim. The FTC seeks a contempt ruling against Shkreli.
Listen to Live Briefing
Real-time synthesized voice briefing · Live Feeds Desk
- ✓ Martin Shkreli livestreamed himself violating the lifetime pharma industry ban.
- ✓ The ban was imposed after a trial found Shkreli guilty of organizing an illegal scheme to monopolize the drug Daraprim.
- ✓ The FTC and seven state attorneys general seek a contempt ruling against Shkreli.
- ✓ Shkreli has 'flagrantly and repeatedly' violated the terms of the ban.
What changed
The FTC and state attorneys general have formally accused Martin Shkreli of violating his lifetime ban and are seeking a contempt ruling.
Live updates
-
Martin Shkreli Livestreamed Violating Pharma Ban: FTC
The FTC and seven state attorneys general allege Martin Shkreli violated his lifetime ban from the pharmaceutical industry. He livestreamed himself discussing industry matters, including biotech stocks. The ban was imposed after a trial found him guilty of organizing an illegal scheme to monopolize the drug Daraprim. The FTC seeks a contempt ruling against Shkreli.
Why it matters
Martin Shkreli, known as the 'Pharma Bro', was banned from the pharmaceutical industry for life. The ban was a result of his involvement in an illegal scheme to perpetuate a monopoly for the drug Daraprim. The FTC and state attorneys general claim Shkreli has repeatedly and flagrantly violated this ban. This case highlights the government's efforts to enforce regulations in the pharmaceutical industry.
What is confirmed
- Martin Shkreli livestreamed himself violating the lifetime pharma industry ban.
- The ban was imposed after a trial found Shkreli guilty of organizing an illegal scheme to monopolize the drug Daraprim.
- The FTC and seven state attorneys general seek a contempt ruling against Shkreli.
- Shkreli has 'flagrantly and repeatedly' violated the terms of the ban.
What to watch next
- The outcome of the FTC's contempt claim against Martin Shkreli
- Potential penalties or sanctions imposed on Shkreli if found in contempt
- The impact on Shkreli's business dealings and assets
confidence 85%Sources used for this update (12)
- arstechnica.com — Ars Technica - Serving the Technologist since 1998. News, reviews, and ...
- www.ftc.gov — Federal Trade Commission | Protecting America's Consumers
- CNBC — Martin Shkreli violated lifetime pharma industry ban, FTC and states say in contempt claim
- The Guardian — FTC and seven states seek contempt ruling against Shkreli over pharma ban
- CNN — ‘Pharma Bro’ Martin Shkreli has caught the attention of federal and state authorities again
- The New York Times — Martin Shkreli Violated Lifetime Ban From Drug Industry, U.S. Says
- Ars Technica — Martin Shkreli livestreamed himself violating lifetime pharma ban, FTC says
- www.inquirer.com — Martin Shkreli should be in contempt for violating lifetime pharma ban, Pa. attorney general says
- www.cnbc.com — Martin Shkreli violated lifetime pharmaceutical ban: FTC - CNBC
- cashwalklabs.io — Martin Shkreli livestreamed himself violating lifetime pharma ban, FTC says | Global Cashwalk
- finance.yahoo.com — FTC says Martin Shkreli 'flagrantly and repeatedly' violated ...
- nypost.com — ‘Pharma Bro’ Martin Shkreli broke lifetime ban on drug ...
Community Sentiment: How do you assess this situation?
Voice your perspective · Real-time aggregated sentiment from the Live Feeds community